Henry A. Nasrallah, MD

Article

The Roles of Efficacy, Safety, and Tolerability in Antipsychotic Effectiveness: Practical Implications of the CATIE Schizophrenia Trial

January 15, 2007

Article

Introduction. Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond

January 15, 2007

Article

Neurologic Comorbidities in Schizophrenia

August 15, 2005

Article

An Overview of Common Medical Comorbidities in Patients With Schizophrenia

August 15, 2005

Academic Highlights

Optimizing Pharmacotherapy to Maximize Outcome in Schizophrenia

January 15, 2005

Original Research

Risperidone in the Treatment of Delirium: Results From a Prospective Open-Label Trial

May 1, 2004

Original Research

Health-Related Quality of Life in Patients With Schizophrenia During Treatment With Long-Acting, Injectable Risperidone

April 1, 2004

Academic Highlights

Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics.

January 1, 2004

Article

Treatment of Bipolar Disorder

May 1, 2003

Article

Efficacy, Safety, and Tolerability of Quetiapine in Patients With Schizophrenia

December 31, 2002

Original Research

Differential Effects of Risperidone, Olanzapine, Clozapine, and Conventional Antipsychotics on Type 2 Diabetes: Findings From a Large Health Plan Database

October 1, 2002

Book Review

In Search of Madness: Schizophrenia and Neuroscience

September 23, 2002